Compazine (prochlorperazine) is a medication used primarily to treat severe nausea and vomiting, though its only current FDA-approved indication is for schizophrenia. In everyday clinical practice, it’s one of the most commonly prescribed anti-nausea drugs in emergency rooms and hospitals, used for everything from post-surgical vomiting to acute migraines. It comes in oral tablets, rectal suppositories, and injectable forms.
How Compazine Works
Compazine belongs to a class of older medications called phenothiazines. It works by blocking dopamine receptors in the brain, specifically in an area called the chemoreceptor trigger zone, which is responsible for detecting toxins in the blood and triggering the urge to vomit. By shutting down dopamine signaling in that region, Compazine effectively suppresses nausea and vomiting at the source. This same dopamine-blocking action is what makes it useful for psychiatric conditions like schizophrenia, where excess dopamine activity plays a role in symptoms like hallucinations and disordered thinking.
Nausea and Vomiting
The most common reason people encounter Compazine is for nausea and vomiting. It’s widely used to manage nausea caused by surgery, chemotherapy, radiation therapy, and general illness. The typical adult dose for nausea is 5 to 10 mg taken by mouth three to four times daily, with a usual maximum of 40 mg per day. Rectal suppositories (25 mg, twice daily) are an option when someone can’t keep oral medication down.
Compazine holds up well against newer anti-nausea drugs. In a randomized, double-blind trial of patients undergoing hip or knee replacement surgery, prochlorperazine outperformed ondansetron (Zofran) for preventing post-operative nausea. Nausea occurred in 56% of the Compazine group compared to 81% of the ondansetron group. Patients on ondansetron were also more likely to need rescue medication (46% vs. 27%). The study, published in JAMA Internal Medicine, found Compazine offered both better results and significant cost savings.
Migraine Treatment in the ER
One of Compazine’s most notable off-label uses is for acute migraine headaches, particularly in emergency departments. It has become a first-line treatment in many ERs because it addresses both the pain and the nausea that often accompany migraines. In head-to-head trials, 10 mg of intravenous prochlorperazine achieved clinical success in 67% to 82% of migraine patients, compared to only 34% to 46% for metoclopramide (Reglan) at the same dose. Emergency medicine guidelines from Academic Life in Emergency Medicine recommend it as the preferred anti-nausea option for acute migraines, typically given alongside an antihistamine to reduce the risk of restlessness as a side effect.
Schizophrenia
Compazine’s sole FDA-approved indication is actually the treatment of schizophrenia, not nausea. For mild psychiatric symptoms, the typical starting dose is 5 to 10 mg three or four times daily. For more severe cases in supervised settings, doses can be gradually increased, with some patients responding well at 50 to 75 mg daily and severe cases sometimes requiring 100 to 150 mg daily. In practice, though, newer antipsychotic medications have largely replaced Compazine for psychiatric use because they tend to cause fewer movement-related side effects.
Side Effects to Know About
The most notable side effects of Compazine involve involuntary movements and muscle reactions. These can include restlessness and an inability to sit still (called akathisia), sudden muscle spasms in the neck or jaw, and a general stiffness or tremor similar to Parkinson’s disease. These reactions are more common at higher doses and tend to affect younger patients more frequently. They’re usually reversible once the medication is stopped or the dose is lowered.
With long-term use, there is a risk of tardive dyskinesia, a condition involving repetitive, involuntary movements of the face and tongue that can sometimes become permanent. This risk increases with the duration of treatment and the total amount taken over time, which is one reason Compazine is generally used for short courses when treating nausea rather than as an ongoing medication.
Drowsiness, dry mouth, constipation, and dizziness are also common. Compazine can lower blood pressure when you stand up quickly, so getting up slowly from a seated or lying position helps reduce lightheadedness.
Who Should Not Take Compazine
Compazine carries an FDA boxed warning for elderly patients with dementia-related psychosis. In analyses of 17 placebo-controlled trials, elderly patients with dementia who took antipsychotic drugs had a death rate of about 4.5% over 10 weeks, compared to 2.6% for those on placebo. That’s roughly 1.6 to 1.7 times the risk. Most of these deaths were cardiovascular (heart failure, sudden death) or related to infections like pneumonia. Compazine is not approved for treating behavioral symptoms in dementia patients.
Children under age 2 should not take Compazine. For children ages 2 to 12, doses are kept much lower, and the medication requires careful monitoring. It is also not appropriate for children under 20 pounds.
Available Forms and Typical Use
Compazine is available in several forms to fit different situations:
- Oral tablets: 5 mg and 10 mg, taken three to four times daily
- Extended-release capsules: 10 mg twice daily or 15 mg once daily
- Rectal suppositories: 25 mg, used twice daily when oral medication isn’t tolerated
- Injectable (IM or IV): used in hospitals and ERs for rapid relief
For most people, Compazine is a short-term medication. You’ll typically take it for a few days to manage an episode of nausea or vomiting, or receive a single dose in the emergency room for a migraine. Long-term use is generally reserved for psychiatric treatment under close supervision, given the movement-related risks that increase over time.